Monitoring plasma nucleosome concentrations to measure of disease response and progression in dogs with hematopoietic malignancies.
H. Wilson-Robles, E. Warry, T. Miller, J. Jarvis, M. Matsushita, P. Miller, M. Herzog, J.-V. Turatsinze, T. K. Kelly, T. K. Butera, G. Michel
This study measures plasma nucleosome concentrations in dogs with hematopoietic malignancies to assess treatment response and disease progression, finding higher concentrations correlate with worse outcomes.
bioRxiv · Feb 2, 2023Cancer Biology